Peter R. Dolan

AAA

DEFINITION of 'Peter R. Dolan'

A former CEO of Bristol-Myers. Dolan joined the company in 1988 and held various senior management positions, becoming president in 2000 and chairman in 2001, a position he held through 2005. Dolan was dismissed in September 2006 because of a patent dispute over the blood-thinning blockbuster drug Plavix, a major source of the company's revenues. The dispute led to major sales losses when a generic equivalent went on the market. Although he was fired, Dolan received a severance package worth $1.2 million and pension benefits worth about $9.5 million.

INVESTOPEDIA EXPLAINS 'Peter R. Dolan'

Born in 1956 in Massachusetts, Dolan earned his MBA from Dartmouth's Tuck School of Business in 1980. Privately-held Gemin X Pharmaceuticals appointed Dolan to its board in 2008. He has also served as chairman of the board of Pharmaceutical Research and Manufacturers of America (PhRMA).

RELATED TERMS
  1. John T. Chambers

    The president and CEO of Cisco Systems, a consumer electronics, ...
  2. Blockbuster Drug

    An extremely popular drug that generates annual sales of at least ...
  3. Chairman

    An executive elected by a company's board of directors that is ...
  4. Corporation

    A legal entity that is separate and distinct from its owners. ...
  5. Board Of Directors - B Of D

    A group of individuals that are elected as, or elected to act ...
  6. Corporate Governance

    The system of rules, practices and processes by which a company ...
Related Articles
  1. Insurance

    Evaluating The Board Of Directors

    Corporate structure can tell you a lot about a company's potential. Learn more here.
  2. Markets

    What Investors Can Learn From Insider Trading

    Some insider trading is actually legal - and can be extremely telling for investors.
  3. Fundamental Analysis

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  4. Markets

    Get Tough On Management Puff

    Company managers are often skilled at fooling investors. Be critical and don't believe the hype.
  5. Fundamental Analysis

    Pharma Patent Trolls: Cheap Drugs At A Steep Price

    Though patent trolls can help patients achieve cheaper medication in the short-term, everyone pays for it in the long term.
  6. Insurance

    Pharmaceutical Phenoms: America's Best-Selling Medicines

    These three drugs were the winners of their day. Find out what winning pharmaceuticals have in common.
  7. Mutual Funds & ETFs

    Investing In The Healthcare Sector

    Perform a thorough checkup to uncover a medical stock with a clean bill of health.
  8. Entrepreneurship

    New Tech Capitals Emerging In Various U.S. States

    While Silicon Valley has long been recognized as the home of tech giants, an increasing number of cities around the country are attracting tech startups.
  9. Stock Analysis

    How MasterCard Likely Earned a Spot in Your Wallet

    An in depth look at MasterCard and its future prospects as an investment.
  10. Investing

    Crowdfunding: Wide Opening For Tech Investors

    Crowdfunding has dramatically changed investing and opened the door for the public to get in on all types of exciting startups, including tech firms.

You May Also Like

Hot Definitions
  1. DuPont Analysis

    A method of performance measurement that was started by the DuPont Corporation in the 1920s. With this method, assets are ...
  2. Asset Class

    A group of securities that exhibit similar characteristics, behave similarly in the marketplace, and are subject to the same ...
  3. Fiat Money

    Currency that a government has declared to be legal tender, but is not backed by a physical commodity. The value of fiat ...
  4. Interest Rate Risk

    The risk that an investment's value will change due to a change in the absolute level of interest rates, in the spread between ...
  5. Income Effect

    In the context of economic theory, the income effect is the change in an individual's or economy's income and how that change ...
  6. Price-To-Sales Ratio - PSR

    A valuation ratio that compares a company’s stock price to its revenues. The price-to-sales ratio is an indicator of the ...
Trading Center